Fifteen researchers from the Radboud University and Radboud university medical center have been awarded a Veni grant by NWO, the Netherlands Organisation for Scientific Research. These grants of up to €250,000 provide highly promising young scientists with the opportunity to further elaborate their own ideas during a period of three years.
Frans Bianchi, theme Cancer development and immune defense received a Veni grant with his project: "Cell surface proteins: an overlooked source of antigens".Diseased cells present pieces of proteins (epitopes) on their surface, allowing their recognition and elimination by the immune system. Many epitopes are generated by unknown mechanisms from membrane-proteins. Using chemical fluorescent reporters, Frans Bianchi will investigate how these are presented.
15 Veni grants for Radboud researchers: more information in this link.
Related news items
T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read moreA single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read moreDutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read moreEuropean grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more